Top Railroad Stocks To Buy For 2014

Since 2008, domestic crude oil production has soared. In fact, the U.S. pumped out more oil last year than it has in at least two decades.

Production has grown so rapidly that midstream companies, which are working tirelessly to build out the pipeline infrastructure necessary to support the domestic oil boom, just can't seem to keep up. We're simply pumping out way too much oil.

That's why railroads and other alternative transport methods have become increasingly important in recent years, giving pipelines a run for their money. And if recent developments are any indication, rail-based crude shipments should continue to grow over the next several years.

That's good news for Warren Buffett's Berkshire Hathaway, which bought out the nation's largest railroad company more than three years ago. Let's see how that bet might turn out.

Buffett's BNSF optimistic about crude shipments
Buffett's decision to take over Burlington Northern Santa Fe LLC, or BNSF, in 2009 was predicated largely upon his belief that a recovering U.S. economy would boost growth in the highly cyclical rail industry. While the bet has turned out to be a great one so far, its future success will likely be driven by further growth in crude oil shipments.

Hot Solar Stocks To Buy For 2015: Donaldson Company Inc (DCI)

Donaldson Company, Inc. (Donaldson) is a worldwide manufacturer of filtration systems and replacement parts. The Company's product mix includes air and liquid filtration systems and exhaust and emission control products. The Company operates in two segments: Engine Products and Industrial Products. Products in the Engine Products segment consist of air filtration systems, exhaust and emissions systems, liquid filtration systems, and replacement filters. Products in the Industrial Products segment consist of dust, fume, and mist collectors, compressed air purification systems, air filtration systems for gas turbines, polytetrafluoroethylene (PTFE) membrane-based products, and specialized air filtration systems for applications including computer hard disk drives. Effective January 14, 2014, Donaldson Co Inc acquired bankrupt Entreprise Dubourg Pere et Fils Sarl.

Donaldson�� products are manufactured at 40 plants around the world and through three joint ventures. The Engine Products segment sells to original equipment manufacturers (OEMs) in the construction, mining, agriculture, aerospace, defense, and truck markets and to OEM dealer networks, independent distributors, private label accounts, and large equipment fleets. The Industrial Products segment sells to various industrial end-users, OEMs of gas-fired turbines and OEMs and end-users requiring clean air.

Advisors' Opinion:

• [By Marc Bastow]

  Filtration parts and systems manufacturer Donaldson (DCI) raised its quarterly dividend 8% to 14 cents per share, payable on Dec. 20th to shareholders of record as of Dec. 9.
  DCI Dividend Yield: 1.33%

• [By Rick Munarriz]

  Friday
  The market is typically quiet on Friday, but that's certainly not the case during earnings season. Donaldson (NYSE: DCI  ) checks in with its latest quarterly results on Friday morning.

• [By Rich Duprey]

  Filtration systems specialist Donaldson� (NYSE: DCI  ) �announced yesterday�its second-quarter dividend of $0.13 per share, a�30% increase from the $0.10 per share payout it made last quarter.

Top Railroad Stocks To Buy For 2014: StemCells Inc (STEM)

StemCells, Inc. (StemCells), incorporated in August 1988, is engaged in the research, development, and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The Company is focused on developing and commercializing stem and progenitor cells as the basis for therapeutics and therapies, and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. The Company�� primary research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The Company has two therapeutic product development programs, including its CNS Program, which is developing applications for HuCNS-SC cells, its human neural stem cell product candidate, and its Liver Program, which is characterizing the Company�� human liver cells as a therapeutic product.

CNS Program

The Company in its CNS Program, is in clinical development with its HuCNS-SC cells for a range of disorders of the central nervous system. The CNS includes the brain, spinal cord and eye. In February 2012, the Company had completed a Phase I clinical trial in Pelizeaus-Merzbacher Disease (PMD), a fatal myelination disorder in the brain.

The Company�� CNS Program is focused on developing clinical applications, in which transplanting HuCNS-SC cells protect or restore organ function of the patient before such function is irreversibly damaged or lost due to disease progression. The Company�� initial target indications are PMD, and more generally, diseases in which deficient myelination plays a central role, such as cerebral palsy or multiple sclerosis; spinal cord injury, disorders in which retinal degeneration plays a central role, such as age-related macular degeneration or retinitis pigmentosa. The Company�� product candidate, HuCNS-SC cells, is a purified and expanded composition of normal human neural stem cells. Its HuCNS-SC cells can be directly transp! lanted.

Liver Program

Liver stem or progenitor cells offer an alternative treatment for liver diseases. A liver cellular therapy or cell-based therapeutic provide or support liver function in patients with liver disease. The Company held a portfolio of issued and allowed patents in the liver field, which cover the isolation and use of both hLEC cells and the isolated subset, as well as the composition of the cells themselves.

The Company�� range of cell culture products, which are sold under the SC Proven brand, includes iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff N2, and NDiff N2B27. Its iSTEM is a serum-free, feeder-free medium that maintains mouse embryonic stem cells in their pluripotent ground state by using selective small molecule inhibitors to block the pathways, which induce differentiation. RHB-A is a defined, serum-free culture medium for the selective culture of human and mouse neural stem cells and their maintenance and expansion as adherent cell populations. RHB-Basal is a defined, serum-free basal medium. When supplemented with specific growth factors, this media is formulated for the propagation and differentiation of adherent neural stem cells. RHB-Basal can also be tailored to specific-cell type requirements by the addition of customer preferred supplements.

The Company�� NDiff N2 is a defined serum-free scell culture supplement for the derivation, maintenance, expansion and/or differentiation of human and mouse embryonic stem (ES) cells and tissue-derived neural stem cells supplement. Its NDiff N2-AF is a serum-free and animal component-free version of NDiff N2. Its NDiff N2B27 is a defined, serum-free medium for the differentiation of mouse embryonic stem cells to neural cell types. NDiff N27-AF is a serum-free and animal component-free version of NDiff N27. Its GS1-R is a serum-free media formulation shown to enable the derivation and long-term maintenance of true, germline competent rat embryonic stem cells without the add! ition of ! cytokines or growth factors. Its GS2-M is a defined, serum- and feeder-free medium for the derivation and long-term maintenance of true, germline competent mouse iPS cells.

The Company also markets a number of antibody reagents for use in cell detection, isolation and characterization. These reagents are also under the SC Proven brand and it includes STEM24, STEM101, STEM121 and STEM123. Its STEM24 is a human antibody that recognizes human CD24, also known as heat stable antigen (HSA), a glycoprotein expressed on the surface of many human cell types, including immature human hematopoietic cells, peripheral blood lymphocytes, erythrocytes and many human carcinomas. Its CD24 is also a marker of human neural differentiation. Its STEM101 is a human-specific mouse antibody that recognizes the Ku80 protein found in human nuclei. Its STEM121 is a human-specific mouse antibody that recognizes a cytoplasmic protein of human cells. Its STEM123 is a human-specific mouse antibody that recognizes human glial fibrillary acidic protein (GFAP).

The Company�� Other products marketed under SC Proven include total cell genomic DNA (gDNA), RNA and protein lysate reagents purified from homogenous stem cell populations for intra-comparative studies, such as Epigenetic fingerprinting, Southern, Western and Northern blots, PCR, RT-PCR and microarrays. This range of purified stem cell line lysates includes mouse embryonic stem (ES) cells propagated in SC Proven 2i inhibitor-based GS2-M media and mouse ES cell-derived and fetal tissue-derived neural stem (NS) cells propagated in SC Proven RHB-A media.

Advisors' Opinion:

• [By Garrett Cook]

  Healthcare shares gained 0.81 percent in the US market on Friday. Top gainers in the sector included Shire plc (NASDAQ: SHPG), StemCells (NASDAQ: STEM), and Flamel Technologies SA (NASDAQ: FLML).

Top Railroad Stocks To Buy For 2014: iShares MSCI Russia Capped ETF (ERUS)

iShares MSCI Russia Capped ETF (the Fund), formerly iShares MSCI Russia Capped Index Fund,, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the MSCI Russia 25/50 Index (the Underlying Index). The Underlying Index is a free-float adjusted market capitalization weighted index designed to measure the performance of equity securities in the top 85% by market capitalization of equity securities listed on stock exchanges in Russia. The Underlying Index is a customized variation of the MSCI Russia Index, designed to cap certain weightings to take into account the investment diversification requirement applicable to regulated investment companies. The Fund�� investment advisor is BlackRock Fund Advisor. Advisors' Opinion:

• [By Charles Sizemore]

  But what exactly are you buying when you buy Russian stocks? Let�� take a look under the hood at the ETFs that track the Russian market: the Market Vectors Russia ETF (RSX), the iShares MSCI Russia Capped Index (ERUS) and the SPDR S&P Russia (RBL).

• [By Barbara Kollmeyer]

  As for U.S. investor exposure, the pain was there for all to see as the week wound down. Among exchange-traded funds, the iShares MSCI Russia ETF (ERUS) �and the SPDR S&P Russia ETF (RBL) �each fell more than 6% for the week, contrasting with a 0.1% gain for the iShares MSCI Emerging Markets ETF (EEM) .

Top Railroad Stocks To Buy For 2014: Rollins Inc. (ROL)

Rollins, Inc., through its subsidiaries, provides pest and termite control services to residential and commercial customers in North America. It offers pest control services, and protection against termite damage, rodents, and insects to homes and businesses, including hotels, food service establishments, food manufacturers, retailers, and transportation companies. The company also provides pest management and sanitation services and products to the food and commodity industries. It operates under the brand names of Orkin and PCO Services brand names, as well as under the Acurid service mark. The company also offers its services in Central America, the Caribbean, the Middle East, Asia, the Mediterranean, and Europe. As of December 31, 2010, it had 56 domestic franchises and 16 international franchises. The company, formerly known as Rollins Broadcasting, Inc., was founded in 1948 and is headquartered in Atlanta, Georgia.

Advisors' Opinion:

• [By Rich Duprey]

  Pest control service provider�Rollins (NYSE: ROL  ) announced yesterday its third-quarter dividend of $0.09 per share, the same rate it's paid for the past two quarters after raising the payout 12.5% from $0.08 per share.

Top Railroad Stocks To Buy For 2014: Profire Energy Inc (PFIE)

Profire Energy, Inc., incorporated on May 5, 2003, is engaged in the business of developing combustion management technologies for the oil and gases industry. The Company manufactures, install and service oilfield combustion management technologies and related products, such as train components and secondary airplates. The Company's primary products are burner management systems. The Company�� Profire 2100 burner management system allows the end-user to manage a variety of combustion vessels. Its Profire 1300 is a flare-ignition system that provides fundamental ignition capabilities for combustor and open-flare vessels, and can relay flame-status. Its Profire 1800 is a mid-range burner management system option that provides fundamental burner management functionality, such as burner re-ignition and temperature management.

The Company also manufactures other technologies and products for sale, including specialized burner management systems intended for use in specific firetube vessels (e.g. incinerators), valve train products, including valves, gauges, and installation products, and miscellaneous componentry, such as solar-power generation kits, add-on cards to expand the functionality of a given system, and a airplate that meters secondary airflow to the burner, allowing for more optimized combustion and reduced emissions.

The Company competes with SureFire, Platinum, ACL and TitanLogix.

Advisors' Opinion:

• [By Peter Graham]

  Small cap green stocks Eco Depot Inc (OTCMKTS: ECDP), Eco Building Products Inc (OTCMKTS: ECOB) and Profire Energy, Inc (OTCBB: PFIE) has been getting some extra attention lately in various investment newsletters thanks to paid promotions or investor relation campaigns. Of course, there is nothing wrong with properly disclosed promotions and investor relations campaigns, but small cap green stocks tend to be extra volatile when compared with other stocks. So how in greenbacks will these three small cap green stocks produce for investors? Here is a quick reality check:

Top Railroad Stocks To Buy For 2014: Beeston Enterprises Ltd (BESE)

Beeston Enterprises Ltd, incorporated on July 12, 1999, is an exploration stage company that engages principally in the acquisition, exploration, and development of resource properties. The Company acquired a 100% interest in 19 mineral claims, comprising over 9,200 hectares, known as the Ruth Lake Property, located 25 kilometers from Lac La Hache, British Columbia, Canada. As of December 31, 2012, the Company owns five mineral claims in this area, all of which are in good standing.

The Company's British Columbia, Canada property is located in the Quesnel Trough. This belt is known for hosting skarn and porphyry copper and copper-gold deposits. The property is being investigated by the Company in Arizona, United States of America is also in a well known gold/silver mining area.

Advisors' Opinion:

• [By Peter Graham]

  Small cap stocks Beeston Enterprises Ltd (OTCMKTS: BESE) and HD Retail Solutions Inc (OTCMKTS: HDRE) surged 33.33% and 11.54%, respectively, on Black Friday while Frontier Beverage Company Inc (OTCMKTS: FBEC) sank 18.18%. And while Black Friday might be the most important shopping day of the year for retailers, its probably not a day that sees a lot of action from investors and traders still digesting their Thanksgiving meals (or busy looking for deals at their favorite retailers). So what direction will these three small cap stocks do for investors and traders this week? Here is a closer look to help you decide:

Top Railroad Stocks To Buy For 2014: Humana Inc.(HUM)

Humana Inc. offers various health and supplemental benefit plans in the United States. Its Government segment consists of beneficiaries of government benefit programs; and operates in three lines of businesses, including Medicare, Military, and Medicaid. The Medicare program provides hospital and medical insurance benefits to persons of age 65 and over and some disabled persons under the age of 65. The Military program offers health insurance coverage to the dependents of duty military personnel, and to retired military personnel and their dependents. The Medicaid program is a federal program that is state-operated to facilitate the delivery of health care services primarily to low-income residents. The Commercial segment consists of members enrolled in its medical and specialty products marketed to employer groups and individuals. This segment provides health maintenance organization products that offer prepaid health insurance coverage to its members through a network of independent primary care physicians, specialty physicians, and other health care providers; preferred provider organization products, which are offered primarily to employer groups and individuals; and administrative services only products that are provided to employers who self-insure their employee health plans. It also offers various specialty products, including dental, vision, and other supplemental products, as well as disease management services. As of December 31, 2010, Humana Inc. had approximately 10.2 million members enrolled in medical benefit plans; and approximately 7.1 million members enrolled in specialty products programs. The company markets its products through various channels comprising television, radio, the Internet, telemarketing, and direct mailings. In addition, it has strategic alliances with Wal-Mart Stores, Inc.; State Farm; and United Services Automobile Association to market its products. The company was founded in 1961 and is headquartered in Louisville, Kentucky.

Advisors' Opinion:

• [By Sean Williams]

  In February, the Centers for Medicare and Medicaid Services, or CMS, proposed a 2.2% reimbursement rate decrease to Medicare Advantage health-benefit providers. Though a bit steeper than many had expected, the reduction proposal followed the basic expectation that the government was going to reduce its cash disbursements to for-profit health-care business. However, following two months of some 160 lawmakers and insurers lobbying the CMS, it decided in April to reverse its decision and propose a 3.3% increase to Medicare Advantage reimbursement rates! At the time, it was great news for Humana (NYSE: HUM  ) and Universal American, which derive about two-thirds and three-quarters of their revenue from Medicare Advantage plans. But, it set an even greater precedence in the sector that health insurers weren't going to cede their pricing power to the government.�

• [By Brandy Betz]

  And it was the reversal of a seemingly adverse change behind a health plans rally last week. After an unfavorable government reimbursement decision for Medicare Advantage plans was reversed, shares of Humana (NYSE: HUM  ) and UnitedHealth Group (NYSE: UNH  ) surged to finish up 13% and 9% for the week, respectively.